Auxa Life Sciences

Auxa Life Sciences is listed as a new startup research supplier in the Scientist.com network, with 1 site in 1 country.

View Auxa Life Sciences on Scientist.com

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: New startup

Brand Communications

Patient-HCP Communication Aids Design and development of tools (visuals, guides, devices) that facilitate clear, accurate, and empathetic two-way dialogue between patients and their healthcare providers.

Clinical Consulting

IND Writing Consulting Consulting for an Investigational New Drug Application

Clinical Trials

Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.

HEOR

Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.

Market Access

Academy of Managed Care Pharmacy (AMCP) Dossier Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Medical Communications

Abstracts Request services related to the writing and review of abstracts
Adverse Events Reports Collecting, documenting, and forwarding reports of side effects or safety issues experienced by patients to the pharmacovigilance team for regulatory reporting.
Advisory Boards Logistical and content support for organizing panels of external experts to gather critical strategic insights and feedback on therapeutic and product development plans.
All Medical Meeting Materials and Content End-to-end service providing slide decks, handouts, training guides, and logistics required to run an internal or external medical meeting successfully.
Development of non promotional Medical Education Plan Creation of a strategic, compliant framework outlining educational needs, target audiences, content objectives, and tactical deployment of medical materials without promoting a product.
Disease or Drug-Related Literature Curation, development, and compliant distribution of written materials (e.g., abstracts, manuscripts, summaries) related to a specific illness or medicinal product.

Show all 28 in Medical Communications 22 more

Fact/Reference Checks Rigorous verification of all scientific claims, data points, and quotations against original source materials to ensure medical and regulatory accuracy.
HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
Internal Evidence Providing organized access and summaries of unpublished company-held data (e.g., clinical study reports) to internal medical and scientific teams.
Investigational Medicinal Product Dossier (IMPD) and Investigational New Drug (IND) Dossier Develop and submit Investigational Medicinal Product Dossier (IMPD) and Investigational New Drug (IND) Dossier
Market & Competitor Analyses Evaluating the current therapeutic landscape, identifying unmet needs, and assessing the scientific positioning and data of competitor products.
Medical Education & Training Creation, development, production and dissemination (internally and externally) of non-promotional disease and treatment-related materials that educate specifically with medicine or healthcare.
Medical Infographics Creation of visually engaging, concise graphic summaries to rapidly convey complex clinical data, scientific concepts, or statistical results.
Medical Information: Sites and Programs Developing online educational platforms or live programs that provide HCPs and patients with comprehensive, compliant, and current medical information.
Medical letters, Emails & Customized Responses Drafting accurate, balanced, and compliant answers to unsolicited scientific and medical inquiries from healthcare professionals or consumers.
Medical Publications Make clear and accurate presentations of scientific and technical data.
Medical Q&As Developing pre-approved, standardized documents containing accurate, balanced answers to anticipated scientific inquiries about a product or disease.
Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
Patient Narratives Compliant collection and use of individual patient stories to illustrate the impact of a disease or treatment, often for training or empathy-building purposes.
Poster Design and Development Design and Develop Posters for Poster Symposiums and conferences to effectively convey science information.
Proactive and Reactive Medical Affairs Assets Development of both planned educational materials and responsive documents used by Medical Affairs to address scientific information gaps.
Protocol and Study Reports Write protocol and study reports, specifically relating to the drafting, writing, and editing of Clinical Safety Reports.
Publication Writing Create further publication documents. Investigational device exemptions (IDEs) BLAs, MAA, PMA, eCTDs, informed consents, CMC and manufacturing reports, orphan drug designations (ODD), briefing books.
Regulatory Submissions and Compliance Draft, format, and submit documents to Pharmaceutical approval agencies according to documentation and guidelines. This includes documents such as NDAs, INDs, SUSARs, AE reporting, RMPs, and PSURS.
Review Article/ Submission Drafting and managing the process of submitting an objective, comprehensive summary of the current literature on a disease or treatment area to a peer-reviewed journal.
Scientific Training Solutions Developing comprehensive educational programs and materials to ensure internal teams, field medical staff, or external partners are fluent in the therapeutic area and product data.
Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...
Therapy Area Disease Insights Report Creation of a comprehensive analysis of the current scientific, clinical, and competitive landscape within a specific therapeutic area.

Show all 43 services 27 more

Old Category HEOR, RWE, Market Access

RWE/HEOR/Market Access Disease/Clinical Outcomes Study the course of disease and the possible outcome of disease, including expected frequency.
RWE/HEOR/Market Access Hybrid Study Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.

Primary Market Research

Positioning and Value Proposition Testing Tests various positioning statements and value messages with target audiences. Refines messaging to maximize resonance and differentiation.

Real World Evidence & Data

RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data

Regulatory Affairs

Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.

Website: www.auxalife.com

United Kingdom Woking 1 site

Work with Auxa Life Sciences on Scientist.com

For prices, more details, or to contact Auxa Life Sciences, visit Scientist.com.

View on Scientist.com